Small Molecule Inhibitors Of P53-S100B Read more about Small Molecule Inhibitors Of P53-S100B US Application 62/632,644Filed on 2018-02-20
EMETINE COMPOUNDS FOR TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION Read more about EMETINE COMPOUNDS FOR TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION US Application 62/570,553Filed on 2017-10-10
EMETINE COMPOUNDS AND COMBINATION THERAPY FOR TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION Read more about EMETINE COMPOUNDS AND COMBINATION THERAPY FOR TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION US Application 62/608,347Filed on 2017-12-20
FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS Read more about FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS US Application 62/671,964Filed on 2018-05-15
QUINOLINE COMPOUNDS AND THEIR PREPARATION AND USE AS ANTIMALARIAL AGENTS Read more about QUINOLINE COMPOUNDS AND THEIR PREPARATION AND USE AS ANTIMALARIAL AGENTS US Application 62/670,351Filed on 2018-05-11
PROCESS FOR SYNTHESIS AND PURIFICATION OF (2R,6R)-HYDROXYNORKETAMINE Read more about PROCESS FOR SYNTHESIS AND PURIFICATION OF (2R,6R)-HYDROXYNORKETAMINE US Application 62/680,183Filed on 2018-06-04
Improved Cell Survival And Differentiation Of Human Pluripotent Stem Cells By Combining Small Molecules Chroman-1 And Emricasan Read more about Improved Cell Survival And Differentiation Of Human Pluripotent Stem Cells By Combining Small Molecules Chroman-1 And Emricasan US Application 62/744,395Filed on 2018-10-11
METHOD OF TREATMENT OF CANCER CELLS EXHIBITING TRAIL RESISTANCE Read more about METHOD OF TREATMENT OF CANCER CELLS EXHIBITING TRAIL RESISTANCE US Application 62/650,147Filed on 2018-03-29
COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NEURODEGENERATIVE DISEASES VIA AUTOPHAGY INDUCTION Read more about COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NEURODEGENERATIVE DISEASES VIA AUTOPHAGY INDUCTION US Application 62/537,260Filed on 2017-07-26
Autophagy Activation By Novel Inducers Prevents BECN2-mediated Drug Tolerance To Cannabinoids Read more about Autophagy Activation By Novel Inducers Prevents BECN2-mediated Drug Tolerance To Cannabinoids US Application 62/450,336Filed on 2017-01-25